Neuroprotexeon Is A Late Clinical Stage Pharmaceutical Company Developing The Proprietary Use Of Xenon Gasdelivered Via A Patented Inhalation Deviceto Protect Against Brain Cell Death Following Acute Neurologic Injurynp Is Currently Preparing For A Phase Iii Clinical Trial In Out Of Hospital Cardiac Arrestohca
No conferences found for this company.
| Company Name | Neuroprotexeon Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.